Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Correction to: Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.

Díaz I, Colantuoni E, Hanley DF, Rosenblum M.

Lifetime Data Anal. 2019 Sep 4. doi: 10.1007/s10985-019-09484-y. [Epub ahead of print]

PMID:
31485927
2.

Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage.

Schoemaker R, Nayak S, Harnisch LO, Karlsson MO; VISTA-ICH Collaboration.

J Pharmacokinet Pharmacodyn. 2019 Aug 29. doi: 10.1007/s10928-019-09653-4. [Epub ahead of print]

PMID:
31468269
3.

Surgery for intracerebral haemorrhage - Authors' reply.

Hanley DF, Ziai WC, Zuccarello M, Awad IA.

Lancet. 2019 Aug 24;394(10199):e22-e23. doi: 10.1016/S0140-6736(19)31416-3. No abstract available.

PMID:
31448744
4.

Blood pressure in intracerebral haemorrhage: which variables matter?

Ziai WC, Gusdon AM, Hanley DF.

Lancet Neurol. 2019 Sep;18(9):810-812. doi: 10.1016/S1474-4422(19)30268-6. No abstract available.

PMID:
31397281
5.

Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.

Leasure AC, Qureshi AI, Murthy SB, Kamel H, Goldstein JN, Walsh KB, Woo D, Shi FD, Huttner HB, Ziai WC, Hanley DF, Matouk CC, Sansing LH, Falcone GJ, Sheth KN.

Stroke. 2019 Aug;50(8):2016-2022. doi: 10.1161/STROKEAHA.119.024838. Epub 2019 Jul 5.

PMID:
31272326
6.

Constructing a confidence interval for the fraction who benefit from treatment, using randomized trial data.

Huang EJ, Fang EX, Hanley DF, Rosenblum M.

Biometrics. 2019 Jun 17. doi: 10.1111/biom.13101. [Epub ahead of print]

PMID:
31206586
7.

Influence of Intracerebral Hemorrhage Location on Outcomes in Patients With Severe Intraventricular Hemorrhage.

Eslami V, Tahsili-Fahadan P, Rivera-Lara L, Gandhi D, Ali H, Parry-Jones A, Nelson LS, Thompson RE, Nekoobakht-Tak S, Dlugash R, McBee N, Awad I, Hanley DF, Ziai WC.

Stroke. 2019 Jul;50(7):1688-1695. doi: 10.1161/STROKEAHA.118.024187. Epub 2019 Jun 10.

PMID:
31177984
8.

Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome.

Ziai WC, Thompson CB, Mayo S, McBee N, Freeman WD, Dlugash R, Ullman N, Hao Y, Lane K, Awad I, Hanley DF; Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) Investigators.

Crit Care Med. 2019 Aug;47(8):1125-1134. doi: 10.1097/CCM.0000000000003848.

PMID:
31162192
9.

Association of Intensive Blood Pressure Reduction With Risk of Hematoma Expansion in Patients With Deep Intracerebral Hemorrhage.

Leasure AC, Qureshi AI, Murthy SB, Kamel H, Goldstein JN, Woo D, Ziai WC, Hanley DF, Al-Shahi Salman R, Matouk CC, Sansing LH, Sheth KN, Falcone GJ.

JAMA Neurol. 2019 May 13. doi: 10.1001/jamaneurol.2019.1141. [Epub ahead of print]

PMID:
31081862
10.

A collaborative, academic approach to optimizing the national clinical research infrastructure: The first year of the Trial Innovation Network.

Bernard GR, Harris PA, Pulley JM, Benjamin DK, Michael J, Ford DE, Hanley DF, Selker HP, Wilkins CH.

J Clin Transl Sci. 2018 Aug;2(4):187-192. doi: 10.1017/cts.2018.319. Epub 2018 Nov 27.

11.

Author response: The systolic blood pressure sweet spot after intracerebral hemorrhage: 130 mm Hg?

Kapinos G, Hanley DF.

Neurology. 2019 Apr 16;92(16):775. doi: 10.1212/WNL.0000000000007308. No abstract available.

PMID:
30988089
12.

A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).

Ziai WC, McBee N, Lane K, Lees KR, Dawson J, Vespa P, Thompson RE, Mendelow AD, Kase CS, Carhuapoma JR, Thompson CB, Mayo SW, Reilly P, Janis S, Anderson CS, Harrigan MR, Camarata PJ, Caron JL, Zuccarello M, Awad IA, Hanley DF; MISTIE III Investigators.

Int J Stroke. 2019 Jul;14(5):548-554. doi: 10.1177/1747493019839280. Epub 2019 Apr 3.

PMID:
30943878
13.

Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure.

Awad IA, Polster SP, Carrión-Penagos J, Thompson RE, Cao Y, Stadnik A, Money PL, Fam MD, Koskimäki J, Girard R, Lane K, McBee N, Ziai W, Hao Y, Dodd R, Carlson AP, Camarata PJ, Caron JL, Harrigan MR, Gregson BA, Mendelow AD, Zuccarello M, Hanley DF; MISTIE III Trial Investigators .

Neurosurgery. 2019 Jun 1;84(6):1157-1168. doi: 10.1093/neuros/nyz077.

PMID:
30891610
14.

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.

Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, Ullman N, Ali H, Carhuapoma JR, Kase CS, Lees KR, Dawson J, Wilson A, Betz JF, Sugar EA, Hao Y, Avadhani R, Caron JL, Harrigan MR, Carlson AP, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine MR, Patel H, Dodd R, Camarata PJ, Wolfe S, Stadnik A, Money PL, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum JS, Wang W, Anderson CS, Mendelow AD, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad IA; MISTIE III Investigators.

Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7. Erratum in: Lancet. 2019 Apr 20;393(10181):1596.

PMID:
30739747
15.

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.

Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskimäki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad IA.

Neurosurgery. 2018 Nov 26. doi: 10.1093/neuros/nyy539. [Epub ahead of print]

PMID:
30476251
16.

Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.

Casella JF, Adams RJ, Brambilla DJ, Strouse JJ, Maier P, Dlugash R, Avadhani R, Vermillion K, Tonascia J, Voeks JH, Hanley DF, Thompson RE, Lehmann HP.

Clin Trials. 2019 Feb;16(1):20-31. doi: 10.1177/1740774518807160. Epub 2018 Nov 14.

PMID:
30426764
17.

Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage.

Toyoda K, Koga M, Yamamoto H, Foster L, Palesch YY, Wang Y, Sakai N, Hara T, Hsu CY, Itabashi R, Sato S, Fukuda-Doi M, Steiner T, Yoon BW, Hanley DF, Qureshi AI; ATACH-2 Trial Investigators.

Ann Neurol. 2019 Jan;85(1):105-113. doi: 10.1002/ana.25379. Epub 2019 Jan 7.

PMID:
30421455
18.

Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial.

Ullman NL, Tahsili-Fahadan P, Thompson CB, Ziai WC, Hanley DF.

Neurocrit Care. 2019 Apr;30(2):380-386. doi: 10.1007/s12028-018-0610-0.

PMID:
30251074
19.

African American Screening and Enrollment in (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III) CLEAR III.

Lane K, Keita M, Avadhani R, Dlugash R, Mayo S, Thompson RE, Awad I, McBee N, Ziai W, Hanley DF.

Clin Res (Alex). 2018 Aug;32(7). pii: https://www.acrpnet.org/2018/08/14/african-american-screening-and-enrollment-in-the-clear-iii-trial/. Epub 2018 Aug 14.

20.

Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

Al-Shahi Salman R, Frantzias J, Lee RJ, Lyden PD, Battey TWK, Ayres AM, Goldstein JN, Mayer SA, Steiner T, Wang X, Arima H, Hasegawa H, Oishi M, Godoy DA, Masotti L, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Jang DK, Davalos A, Castillo J, Yao X, Claassen J, Volbers B, Kazui S, Okada Y, Fujimoto S, Toyoda K, Li Q, Khoury J, Delgado P, Sabín JÁ, Hernández-Guillamon M, Prats-Sánchez L, Cai C, Kate MP, McCourt R, Venkatasubramanian C, Diringer MN, Ikeda Y, Worthmann H, Ziai WC, d'Esterre CD, Aviv RI, Raab P, Murai Y, Zazulia AR, Butcher KS, Seyedsaadat SM, Grotta JC, Martí-Fàbregas J, Montaner J, Broderick J, Yamamoto H, Staykov D, Connolly ES, Selim M, Leira R, Moon BH, Demchuk AM, Di Napoli M, Fujii Y, Anderson CS, Rosand J; VISTA-ICH Collaboration; ICH Growth Individual Patient Data Meta-analysis Collaborators.

Lancet Neurol. 2018 Oct;17(10):885-894. doi: 10.1016/S1474-4422(18)30253-9. Epub 2018 Aug 14. Erratum in: Lancet Neurol. 2018 Sep 19;:.

21.

The systolic blood pressure sweet spot after intracerebral hemorrhage: 130 mm Hg?

Kapinos G, Hanley DF Jr.

Neurology. 2018 Sep 11;91(11):495-496. doi: 10.1212/01.wnl.0000544245.04683.a1. Epub 2018 Aug 10. No abstract available.

PMID:
30097478
22.

Ultrastructural Characteristics of Neuronal Death and White Matter Injury in Mouse Brain Tissues After Intracerebral Hemorrhage: Coexistence of Ferroptosis, Autophagy, and Necrosis.

Li Q, Weiland A, Chen X, Lan X, Han X, Durham F, Liu X, Wan J, Ziai WC, Hanley DF, Wang J.

Front Neurol. 2018 Jul 17;9:581. doi: 10.3389/fneur.2018.00581. eCollection 2018.

23.

Blood Pressure-Attained Analysis of ATACH 2 Trial.

Qureshi AI, Palesch YY, Foster LD, Barsan WG, Goldstein JN, Hanley DF, Hsu CY, Moy CS, Qureshi MH, Silbergleit R, Suarez JI, Toyoda K, Yamamoto H; ATACH 2 Trial Investigators.

Stroke. 2018 Jun;49(6):1412-1418. doi: 10.1161/STROKEAHA.117.019845. Epub 2018 May 22.

PMID:
29789395
24.

Influence of Bleeding Pattern on Ischemic Lesions After Spontaneous Hypertensive Intracerebral Hemorrhage with Intraventricular Hemorrhage.

Rivera-Lara L, Murthy SB, Nekoovaght-Tak S, Ali H, McBee N, Dlugash R, Ram M, Thompson R, Awad IA, Hanley DF, Ziai WC; CLEAR Investigators.

Neurocrit Care. 2018 Oct;29(2):180-188. doi: 10.1007/s12028-018-0516-x.

PMID:
29589328
25.

Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.

Díaz I, Colantuoni E, Hanley DF, Rosenblum M.

Lifetime Data Anal. 2019 Jul;25(3):439-468. doi: 10.1007/s10985-018-9428-5. Epub 2018 Feb 28. Erratum in: Lifetime Data Anal. 2019 Sep 4;:.

PMID:
29492746
26.

Changes in motor function, cognition, and emotion-related behavior after right hemispheric intracerebral hemorrhage in various brain regions of mouse.

Zhu W, Gao Y, Wan J, Lan X, Han X, Zhu S, Zang W, Chen X, Ziai W, Hanley DF, Russo SJ, Jorge RE, Wang J.

Brain Behav Immun. 2018 Mar;69:568-581. doi: 10.1016/j.bbi.2018.02.004. Epub 2018 Feb 16.

28.

Lack of Early Improvement Predicts Poor Outcome Following Acute Intracerebral Hemorrhage.

Yogendrakumar V, Smith EE, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Silva Blas Y, Dzialowski I, Kobayashi A, Boulanger JM, Lum C, Gubitz G, Padma V, Roy J, Kase CS, Bhatia R, Ali M, Lyden P, Hill MD, Dowlatshahi D; Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign [PREDICT]/Sunnybrook ICH CTA Study Group and the Virtual International Stroke Trials Archive (VISTA)-ICH Collaborators.

Crit Care Med. 2018 Apr;46(4):e310-e317. doi: 10.1097/CCM.0000000000002962.

PMID:
29303797
29.

Abstracts from Hydrocephalus 2016.

Adam A, Robison J, Lu J, Jose R, Badran N, Vivas-Buitrago T, Rigamonti D, Sattar A, Omoush O, Hammad M, Dawood M, Maghaslah M, Belcher T, Carson K, Hoffberger J, Jusué Torres I, Foley S, Yasar S, Thai QA, Wemmer J, Klinge P, Al-Mutawa L, Al-Ghamdi H, Carson KA, Asgari M, de Zélicourt D, Kurtcuoglu V, Garnotel S, Salmon S, Balédent O, Lokossou A, Page G, Balardy L, Czosnyka Z, Payoux P, Schmidt EA, Zitoun M, Sevestre MA, Alperin N, Baudracco I, Craven C, Matloob S, Thompson S, Haylock Vize P, Thorne L, Watkins LD, Toma AK, Bechter K, Pong AC, Jugé L, Bilston LE, Cheng S, Bradley W, Hakim F, Ramón JF, Cárdenas MF, Davidson JS, García C, González D, Bermúdez S, Useche N, Mejía JA, Mayorga P, Cruz F, Martinez C, Matiz MC, Vallejo M, Ghotme K, Soto HA, Riveros D, Buitrago A, Mora M, Murcia L, Bermudez S, Cohen D, Dasgupta D, Curtis C, Domínguez L, Remolina AJ, Grijalba MA, Whitehouse KJ, Edwards RJ, Eleftheriou A, Lundin F, Fountas KN, Kapsalaki EZ, Smisson HF, Robinson JS, Fritsch MJ, Arouk W, Garzon M, Kang M, Sandhu K, Baghawatti D, Aquilina K, James G, Thompson D, Gehlen M, Schmid Daners M, Eklund A, Malm J, Gomez D, Guerra M, Jara M, Flores M, Vío K, Moreno I, Rodríguez S, Ortega E, Rodríguez EM, McAllister JP, Guerra MM, Morales DM, Sival D, Jimenez A, Limbrick DD, Ishikawa M, Yamada S, Yamamoto K, Junkkari A, Häyrinen A, Rauramaa T, Sintonen H, Nerg O, Koivisto AM, Roine RP, Viinamäki H, Soininen H, Luikku A, Jääskeläinen JE, Leinonen V, Kehler U, Lilja-Lund O, Kockum K, Larsson EM, Riklund K, Söderström L, Hellström P, Laurell K, Kojoukhova M, Sutela A, Vanninen R, Vanha KI, Timonen M, Rummukainen J, Korhonen V, Helisalmi S, Solje E, Remes AM, Huovinen J, Paananen J, Hiltunen M, Kurki M, Martin B, Loth F, Luciano M, Luikku AJ, Hall A, Herukka SK, Mattila J, Lötjönen J, Alafuzoff I, Jurjević I, Miyajima M, Nakajima M, Murai H, Shin T, Kawaguchi D, Akiba C, Ogino I, Karagiozov K, Arai H, Reis RC, Teixeira MJ, Valêncio CG, da Vigua D, Almeida-Lopes L, Mancini MW, Pinto FCG, Maykot RH, Calia G, Tornai J, Silvestre SSS, Mendes G, Sousa V, Bezerra B, Dutra P, Modesto P, Oliveira MF, Petitto CE, Pulhorn H, Chandran A, McMahon C, Rao AS, Jumaly M, Solomon D, Moghekar A, Relkin N, Hamilton M, Katzen H, Williams M, Bach T, Zuspan S, Holubkov R, Rigamonti A, Clemens G, Sharkey P, Sanyal A, Sankey E, Rigamonti K, Naqvi S, Hung A, Schmidt E, Ory-Magne F, Gantet P, Guenego A, Januel AC, Tall P, Fabre N, Mahieu L, Cognard C, Gray L, Buttner-Ennever JA, Takagi K, Onouchi K, Thompson SD, Thorne LD, Tully HM, Wenger TL, Kukull WA, Doherty D, Dobyns WB, Moran D, Vakili S, Patel MA, Elder B, Goodwin CR, Crawford JA, Pletnikov MV, Xu J, Blitz A, Herzka DA, Guerrero-Cazares H, Quiñones-Hinojosa A, Mori S, Saavedra P, Treviño H, Maitani K, Ziai WC, Eslami V, Nekoovaght-Tak S, Dlugash R, Yenokyan G, McBee N, Hanley DF.

Fluids Barriers CNS. 2017 Jun 7;14(Suppl 1):15. doi: 10.1186/s12987-017-0054-5. No abstract available.

30.

Fibrinolytic for treatment of intraventricular hemorrhage: A meta-analysis and systematic review.

Baker AD, Rivera Perla KM, Yu Z, Dlugash R, Avadhani R, Mould WA, Ziai W, Thompson RE, Staykov D, Hanley DF.

Int J Stroke. 2018 Jan;13(1):11-23. doi: 10.1177/1747493017730745. Epub 2017 Sep 18. Review.

PMID:
28920538
31.

CSF inflammatory response after intraventricular hemorrhage.

Fam MD, Zeineddine HA, Eliyas JK, Stadnik A, Jesselson M, McBee N, Lane K, Cao Y, Wu M, Zhang L, Thompson RE, John S, Ziai W, Hanley DF, Awad IA; CLEAR III Trial Investigators.

Neurology. 2017 Oct 10;89(15):1553-1560. doi: 10.1212/WNL.0000000000004493. Epub 2017 Sep 8.

32.

Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.

Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron JL, Huang J, Camarata P, Lara LR, Dlugash R, McBee N, Eslami V, Hanley DF, Ziai WC; CLEAR III Trial Investigators.

Neurology. 2017 Jul 25;89(4):355-362. doi: 10.1212/WNL.0000000000004155. Epub 2017 Jun 28.

33.

Adaptive Enrichment Designs for Stroke Clinical Trials.

Rosenblum M, Hanley DF.

Stroke. 2017 Jul;48(7):2021-2025. doi: 10.1161/STROKEAHA.116.015342. Epub 2017 May 23. Review. No abstract available.

PMID:
28536178
34.

Motor recovery beginning 23 years after ischemic stroke.

Sörös P, Teasell R, Hanley DF, Spence JD.

J Neurophysiol. 2017 Aug 1;118(2):778-781. doi: 10.1152/jn.00868.2016. Epub 2017 May 17.

35.

Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.

Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, Sheth KN, Hanley DF, Ziai WC, Kamel H.

Stroke. 2017 Jun;48(6):1594-1600. doi: 10.1161/STROKEAHA.116.016327. Epub 2017 Apr 17. Review.

36.

Classification of Different Degrees of Disability Following Intracerebral Hemorrhage: A Decision Tree Analysis from VISTA-ICH Collaboration.

Phan TG, Chen J, Beare R, Ma H, Clissold B, Van Ly J, Srikanth V; VISTA-ICH Collaboration.

Front Neurol. 2017 Feb 28;8:64. doi: 10.3389/fneur.2017.00064. eCollection 2017.

37.

PItcHPERFeCT: Primary Intracranial Hemorrhage Probability Estimation using Random Forests on CT.

Muschelli J, Sweeney EM, Ullman NL, Vespa P, Hanley DF, Crainiceanu CM.

Neuroimage Clin. 2017 Feb 15;14:379-390. doi: 10.1016/j.nicl.2017.02.007. eCollection 2017.

38.

Vorapaxar and Amyotrophic Lateral Sclerosis: Coincidence or Adverse Association?

Serebruany VL, Fortmann SD, Hanley DF, Kim MH.

Am J Ther. 2017 Mar/Apr;24(2):e139-e143. doi: 10.1097/MJT.0000000000000395. Review.

PMID:
28267691
39.

Erratum: Medical and Surgical Advances in Intracerebral Hemorrhage and Intraventricular Hemorrhage.

Ziai W, Carhuapoma JR, Nyquist P, Hanley DF.

Semin Neurol. 2017 Feb;37(1):103-104. doi: 10.1055/s-0037-1598083. Epub 2017 Feb 1. No abstract available.

PMID:
28147425
40.

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.

Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, Dawson J, Gandhi D, Ullman N, Mould WA, Mayo SW, Mendelow AD, Gregson B, Butcher K, Vespa P, Wright DW, Kase CS, Carhuapoma JR, Keyl PM, Diener-West M, Muschelli J, Betz JF, Thompson CB, Sugar EA, Yenokyan G, Janis S, John S, Harnof S, Lopez GA, Aldrich EF, Harrigan MR, Ansari S, Jallo J, Caron JL, LeDoux D, Adeoye O, Zuccarello M, Adams HP Jr, Rosenblum M, Thompson RE, Awad IA; CLEAR III Investigators.

Lancet. 2017 Feb 11;389(10069):603-611. doi: 10.1016/S0140-6736(16)32410-2. Epub 2017 Jan 10.

41.

Improving precision by adjusting for prognostic baseline variables in randomized trials with binary outcomes, without regression model assumptions.

Steingrimsson JA, Hanley DF, Rosenblum M.

Contemp Clin Trials. 2017 Mar;54:18-24. doi: 10.1016/j.cct.2016.12.026. Epub 2017 Jan 4.

PMID:
28064029
42.

Inequality in treatment benefits: Can we determine if a new treatment benefits the many or the few?

Huang EJ, Fang EX, Hanley DF, Rosenblum M.

Biostatistics. 2017 Apr 1;18(2):308-324. doi: 10.1093/biostatistics/kxw049.

43.

Primary intraventricular hemorrhage in adults: etiological causes and prognostic factors in Chinese population.

Zhang S, Jia B, Li H, You C, Hanley DF, Jiang Y.

J Neurol. 2017 Feb;264(2):382-390. doi: 10.1007/s00415-016-8367-x. Epub 2016 Dec 20.

PMID:
28000008
44.

Medical and Surgical Advances in Intracerebral Hemorrhage and Intraventricular Hemorrhage.

Ziai W, Carhuapoma JR, Nyquist P, Hanley DF.

Semin Neurol. 2016 Dec;36(6):531-541. Epub 2016 Dec 1. Review. Erratum in: Semin Neurol. 2017 Feb;37(1):103-104.

PMID:
27907957
45.

Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.

Hanley DF, Thompson RE, Muschelli J, Rosenblum M, McBee N, Lane K, Bistran-Hall AJ, Mayo SW, Keyl P, Gandhi D, Morgan TC, Ullman N, Mould WA, Carhuapoma JR, Kase C, Ziai W, Thompson CB, Yenokyan G, Huang E, Broaddus WC, Graham RS, Aldrich EF, Dodd R, Wijman C, Caron JL, Huang J, Camarata P, Mendelow AD, Gregson B, Janis S, Vespa P, Martin N, Awad I, Zuccarello M; MISTIE Investigators.

Lancet Neurol. 2016 Nov;15(12):1228-1237. doi: 10.1016/S1474-4422(16)30234-4. Epub 2016 Oct 11.

46.

Applicability of Clinical Trials in an Unselected Cohort of Patients With Intracerebral Hemorrhage.

Hansen BM, Ullman N, Norrving B, Hanley DF, Lindgren A.

Stroke. 2016 Oct;47(10):2634-7. doi: 10.1161/STROKEAHA.116.014203. Epub 2016 Sep 13.

47.

Intracerebral Hemorrhage Outcomes in Patients with Systemic Cancer.

Murthy SB, Shastri A, Merkler AE, Hanley DF, Ziai WC, Fink ME, Iadecola C, Kamel H, Navi BB.

J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2918-2924. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.006. Epub 2016 Aug 25.

48.

Rate of perihaematomal oedema expansion is associated with poor clinical outcomes in intracerebral haemorrhage.

Murthy SB, Urday S, Beslow LA, Dawson J, Lees K, Kimberly WT, Iadecola C, Kamel H, Hanley DF, Sheth KN, Ziai WC; VISTA ICH Collaborators.

J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1169-1173. doi: 10.1136/jnnp-2016-313653. Epub 2016 Jul 27.

49.

Nosocomial Infections and Outcomes after Intracerebral Hemorrhage: A Population-Based Study.

Murthy SB, Moradiya Y, Shah J, Merkler AE, Mangat HS, Iadacola C, Hanley DF, Kamel H, Ziai WC.

Neurocrit Care. 2016 Oct;25(2):178-84. doi: 10.1007/s12028-016-0282-6.

PMID:
27350549
50.

Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.

Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW; ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network.

N Engl J Med. 2016 Sep 15;375(11):1033-43. doi: 10.1056/NEJMoa1603460. Epub 2016 Jun 8.

Supplemental Content

Loading ...
Support Center